Melatonin Receptor 1B anticorps

N° du produit ABIN637000

Détail du produit anti-Melatonin Receptor 1B anticorps

Antigène: Melatonin Receptor 1B (MTNR1B)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Melatonin Receptor 1B est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Purification: Affinity chromatography purified

Immunogène: MTNR1 B antibody was raised in rabbit using a synthetic peptide conjugated to KLH as the immunogen.

Information d'application

Indications d'application: IHC-P: 5 µg/mL
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Purified by Immunoaffinity Chromatography and supplied in PBS with 0.1 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -70 °C for long term storage.

Détails sur Melatonin Receptor 1B

Antigène: Melatonin Receptor 1B (MTNR1B)

Autre désignation: MTNR1B (MTNR1B Produits)

Synonymes: anticorps FGQTL2, anticorps MEL-1B-R, anticorps MT2, anticorps Mel1b-r, anticorps Mel-1B-R, anticorps MTNR1B, anticorps mtnr1br, anticorps MEL1B, anticorps Mel1b, anticorps Mt2, anticorps mel1b, anticorps mtnr1b, anticorps melatonin receptor 1B, anticorps melatonin receptor type 1C S homeolog, anticorps melatonin receptor type 1Ba, anticorps MTNR1B, anticorps Mtnr1b, anticorps mtnr1c.S, anticorps mtnr1bb, anticorps mtnr1ba

Sujet: Melatonin receptor 1B, also known as MTNR1B, is a protein that in humans is encoded by the MTNR1B gene. This gene encodes the MT2 protein, one of two high-affinity forms of a receptor for melatonin, the primary hormone secreted by the pineal gland. Several studies have identified MTNR1B receptor mutations that are associated with increased average blood sugar level and around a 20 percent elevated risk of developing type 2 diabetes.